About Manus Bio
Manus Bio is a private company based in Waltham, Massachusetts. It has reported $118,033,201 raised in six offerings on Form D since October 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 8, 2024 | May 14, 2024 | $11,270,003fully sold | 6 | $1.8M | Equity, Options, Securities on exercise, Common Stock to be acquired upon exercise of option.Rule 506(b) | Form D ↗ |
| Aug 20, 2021 | May 31, 2023 | $21,225,000of $22.2M target | 14 | $1.5M | Equity, Debt, Options, Securities on exercise, Convertible promissory notes; Equity securities underlying convertible promissory notes.Rule 506(b) | Form D ↗ |
| Apr 16, 2020 | Nov 6, 2020amended Nov 9, 2020 | $66,187,702of $80.0M target | 27 | $2.4M | Equity, Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series B-3 Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 12, 2018 | Jul 16, 2018 | $10,000,000of $12.0M target | 15 | $666K | Equity, Options, Series A-1 Preferred Stock and Warrants to purchase Series A-1 Preferred StockRule 506(b) | Form D ↗ |
| Aug 31, 2017 | Aug 23, 2017amended Dec 29, 2017 | $9,050,496of $10.0M target | 24 | $377K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 30, 2016 | Oct 12, 2016 | $300,000of $3.0M target | 2 | $150K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $118,033,201 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Manus Bio's Form D filed May 14, 2024.
Earlier filings also listed John Nehme (director, last listed May 2023), Jeremiah Hux (executive officer, last listed May 2023), Ajikumar Parayil (executive officer and director, last listed May 2023), Zanna McFerson (director, last listed Nov 2020), Raymond Chang (director, last listed Nov 2020), Paul Boni (executive officer, last listed Nov 2020), Jeff Anderson (executive officer, last listed Nov 2020) and Gregory Stephanopoulos (director, last listed Nov 2020).